Glycyrrhizin attenuates the development of carrageenan-induced lung injury in mice

Pharmacol Res. 2008 Jul;58(1):22-31. doi: 10.1016/j.phrs.2008.05.012. Epub 2008 Jun 11.

Abstract

Glycyrrhizin is a triterpene glycoside, a major active constituent of licorice (Glycyrrhiza glabra) root and numerous pharmacological effects like anti-inflammatory, anti-viral, anti-tumour and hepatoprotective activities has been attributed to it. In this study we evaluated the anti-inflammatory activities of glycyrrhizin in mice model of acute inflammation, carrageenan-induced pleurisy. We report here that glycyrrhizin (given at 10 mg/kg i.p. 5 min prior to carrageenan) exerts potent anti-inflammatory effects in this model. Injection of carrageenan into the pleural cavity of mice elicited an acute inflammatory response characterized by fluid accumulation in the pleural cavity which contained a large number of neutrophils (PMNs) as well as an infiltration of PMNs in lung tissues and subsequent lipid peroxidation (as determinated by thiobarbituric acid-reactant substances measurement) and increased production of tumour necrosis factor-alpha (TNF-alpha) and interleukin-1beta (IL-1beta). All these parameters were attenuated by glycyrrhizin. Furthermore, carrageenan induced an upregulation of the expression of intercellular cell adhesion molecule (ICAM-1), P-selectin, as well as an increase in the amounts of nitrotyrosine and poly(ADP-ribose) (PAR), as determined by immunohistochemical analysis of lung tissues. The degree of staining for the ICAM-1, P-selectin, nitrotyrosine and PAR was significantly reduced by glycyrrhizin. Additionally, we demonstrate that these inflammatory events were associated with the activation of nuclear factor-kappaB (NF-kappaB) and signal transducer and activator transcription-3 (STAT-3) activation in the lung. NF-kappaB and STAT-3 activation were significantly reduced by glycyrrhizin treatment. Taken together, our results indicate that prevention of the activation of NF-kappaB and STAT-3 by glycyrrhizin reduces the development of acute inflammation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology*
  • Carrageenan
  • Enzyme Activation
  • Glycyrrhizic Acid / pharmacology*
  • Intercellular Adhesion Molecule-1 / biosynthesis
  • Interleukin-1beta / biosynthesis
  • Lipid Peroxidation / drug effects
  • Lung / drug effects*
  • Lung / metabolism
  • Lung / pathology
  • Male
  • Mice
  • NF-kappa B / metabolism
  • Neutrophils / drug effects
  • Neutrophils / physiology
  • P-Selectin / biosynthesis
  • Peroxynitrous Acid / metabolism
  • Pleurisy / chemically induced
  • Pleurisy / pathology
  • Pleurisy / prevention & control*
  • Poly Adenosine Diphosphate Ribose / metabolism
  • STAT3 Transcription Factor / metabolism
  • Tumor Necrosis Factor-alpha / biosynthesis
  • Tyrosine / analogs & derivatives
  • Tyrosine / metabolism

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Interleukin-1beta
  • NF-kappa B
  • P-Selectin
  • STAT3 Transcription Factor
  • Tumor Necrosis Factor-alpha
  • Intercellular Adhesion Molecule-1
  • Peroxynitrous Acid
  • Poly Adenosine Diphosphate Ribose
  • 3-nitrotyrosine
  • Tyrosine
  • Glycyrrhizic Acid
  • Carrageenan